These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21166862)

  • 1. Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis.
    Gavhed D; Laurencikas E; Akefeldt SO; Henter JI
    Acta Paediatr; 2011 Jul; 100(7):e36-9. PubMed ID: 21166862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy.
    Imashuku S; Okazaki N'; Nakayama M; Fujita N; Fukuyama T; Koike K; Minato T; Kobayashi R; Morimoto A;
    Pediatr Blood Cancer; 2008 Feb; 50(2):308-11. PubMed ID: 17458874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VCR/AraC chemotherapy and ND-CNS-LCH.
    Imashuku S; Shioda Y; Tsunematsu Y; Imamura T; Morimoto A;
    Pediatr Blood Cancer; 2010 Jul; 55(1):215-6. PubMed ID: 20310001
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
    Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
    Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
    Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
    Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans cell histiocytosis: central nervous system involvement treated successfully with 2-chlorodeoxyadenosine.
    Watts J; Files B
    Pediatr Hematol Oncol; 2001; 18(3):199-204. PubMed ID: 11293288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
    Davidson L; McComb JG; Bowen I; Krieger MD
    J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern and course of neurodegeneration in Langerhans cell histiocytosis.
    Wnorowski M; Prosch H; Prayer D; Janssen G; Gadner H; Grois N
    J Pediatr; 2008 Jul; 153(1):127-32. PubMed ID: 18571550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the Histiocyte Society workshop on "Central nervous system (CNS) disease in Langerhans cell histiocytosis (LCH)".
    Med Pediatr Oncol; 1997 Aug; 29(2):73-8. PubMed ID: 9180906
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
    Allen CE; Flores R; Rauch R; Dauser R; Murray JC; Puccetti D; Hsu DA; Sondel P; Hetherington M; Goldman S; McClain KL
    Pediatr Blood Cancer; 2010 Mar; 54(3):416-23. PubMed ID: 19908293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study.
    Laurencikas E; Gavhed D; Stålemark H; van't Hooft I; Prayer D; Grois N; Henter JI
    Pediatr Blood Cancer; 2011 Feb; 56(2):250-7. PubMed ID: 21157893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS.
    Imashuku S
    CNS Neurol Disord Drug Targets; 2015; 14(6):688-90. PubMed ID: 26008858
    [No Abstract]   [Full Text] [Related]  

  • 15. Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
    Baumann M; Cerny T; Sommacal A; Koeberle D
    Hematol Oncol; 2012 Jun; 30(2):101-4. PubMed ID: 21732400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.
    Ehrhardt MJ; Karst J; Donohoue PA; Maheshwari M; McClain KL; Bingen K; Kelly ME
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e37-40. PubMed ID: 24322503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study.
    Ng Wing Tin S; Martin-Duverneuil N; Idbaih A; Garel C; Ribeiro M; Parker JL; Defachelles AS; Lambilliotte A; Barkaoui M; Munzer M; Gardembas M; Sibilia J; Lutz P; Fior R; Polak M; Robert A; Aumaitre O; Plantaz D; Armari-Alla C; Genereau T; Berard PM; Talom GN; Pennaforte JL; Le Pointe HD; Barthez MA; Couillault G; Haroche J; Mokhtari K; Donadieu J; Hoang-Xuan K;
    Orphanet J Rare Dis; 2011 Dec; 6():83. PubMed ID: 22151964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
    Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
    Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
    Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.